Refractive Surgery

>

Latest News

Opus Genetics releases topline results from LYNX-2 evaluating phentolamine ophthalmic solution 0.75%
Opus Genetics releases topline results from LYNX-2 evaluating phentolamine ophthalmic solution 0.75%

June 2nd 2025

The phase 3 trial observed the treatment of chronic night driving impairment in keratorefractive patients with reduced mesopic vision.

Q&A: Continuum of care, the evolution of cornea, cataract, and refractive surgery
Q&A: Continuum of care, the evolution of cornea, cataract, and refractive surgery

April 26th 2025

Alcon agrees to purchase LENSAR
Alcon agrees to purchase LENSAR

March 25th 2025

ARVO announces recipients of the 2025 ARVO Foundation Early Career Clinician-Scientist Awards
ARVO announces recipients of the 2025 ARVO Foundation Early Career Clinician-Scientist Awards

March 16th 2025

A clinician uses the The VISUMAX 800 with SMILE pro software. Image courtesy Carl Zeiss Meditec AG.
China issues approval for Zeiss Visumax 800 with SMILE pro software

February 26th 2025

Video Interviews
Podcasts
EnVision Summit 2025: Advancing Ophthalmology and Optometry Together

More News

© 2025 MJH Life Sciences

All rights reserved.